U S PHYSICAL THERAPY INC /NV Earnings Per Share, Basic and Diluted
U S PHYSICAL THERAPY INC /NV (USPH) reported Earnings Per Share, Basic and Diluted of $2.41 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-01
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for the quarter ending 2020-09-30 was $0.61, a 7.58% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for the quarter ending 2020-06-30 was $0.99, a 16.47% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for the quarter ending 2020-03-31 was $0.20, a 48.72% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for the quarter ending 2019-12-31 was $0.55, a 27.91% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for fiscal 2021 was $2.41, a 2.82% decline from fiscal 2020.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for fiscal 2020 was $2.48, a 1.22% increase from fiscal 2019.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for fiscal 2019 was $2.45, a 87.02% increase from fiscal 2018.
- U S PHYSICAL THERAPY INC /NV earnings per share, basic and diluted for fiscal 2018 was $1.31, a 25.57% decline from fiscal 2017.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $2.41 10-K · filed 2022-03-01 | |||||
| 2020-12-31 | $2.48 10-K · filed 2022-03-01 | |||||
| 2020-09-30 | $0.61 10-Q · filed 2020-11-06 | $1.80 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $0.99 10-Q · filed 2020-08-07 | $1.19 10-Q · filed 2020-08-07 | ||||
| 2020-03-31 | $0.20 10-Q · filed 2020-05-21 | |||||
| 2019-12-31 | $0.55 10-K · filed 2020-02-28 | $2.45 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $0.66 10-Q · filed 2020-11-06 | $1.90 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | $0.85 10-Q · filed 2020-08-07 | $1.24 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | $0.39 10-Q · filed 2020-05-21 | |||||
| 2018-12-31 | $0.43 10-K · filed 2020-02-28 | $1.31 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $0.13 10-K · filed 2020-02-28 | $0.88 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | $0.48 10-K · filed 2020-02-28 | $0.74 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | $0.27 10-K · filed 2020-02-28 | |||||
| 2017-12-31 | $0.57 10-K · filed 2019-03-18 | $1.76 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | $0.41 10-K · filed 2019-03-18 | $1.19 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | $0.39 10-K · filed 2019-03-18 | $0.78 10-Q · filed 2018-08-07 | ||||
| 2017-03-31 | $0.38 10-K · filed 2019-03-18 | |||||
| 2016-12-31 | $0.42 10-K · filed 2018-03-14 | $0.72 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.50 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.64 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $0.38 10-K · filed 2018-03-14 | $0.46 10-Q · filed 2016-11-04 | $1.41 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.22 10-Q · filed 2017-11-07 | $1.45 10-Q · filed 2016-11-04 | $2.31 derived: net income ÷ weighted average shares · filed 2018-03-14 |
| 2016-06-30 | $0.48 10-K · filed 2018-03-14 | $0.84 10-Q · filed 2017-08-07 | $1.68 derived: net income ÷ weighted average shares · filed 2018-03-14 | $2.31 derived: net income ÷ weighted average shares · filed 2018-03-14 | ||
| 2016-03-31 | $0.36 10-K · filed 2018-03-14 | $0.43 10-Q · filed 2016-05-06 | $0.90 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.54 derived: net income ÷ weighted average shares · filed 2018-03-14 | $2.25 derived: net income ÷ weighted average shares · filed 2018-03-14 | |
| 2015-12-31 | $0.38 10-K · filed 2017-06-07 | $0.93 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.65 derived: net income ÷ weighted average shares · filed 2018-03-14 | $1.66 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $0.44 10-K · filed 2017-06-07 | $0.47 10-Q · filed 2016-11-04 | $1.36 derived: net income ÷ weighted average shares · filed 2017-06-07 | $1.28 10-K · filed 2017-06-07 | $1.29 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $0.51 10-K · filed 2017-06-07 | $0.84 10-K · filed 2017-06-07 | ||||
| 2015-03-31 | $0.33 10-K · filed 2017-06-07 | $0.34 10-Q · filed 2016-05-06 | ||||
| 2014-12-31 | $1.57 10-K · filed 2017-06-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |